Keros Therapeutics, Inc. - COM (KROS)

Historical Portfolio Holders from Q2 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
31.1 M
Holdings value Q1 2024
$2.06 B
Value change Q1 2024
+$418 M
Grand Portfolio weight change Q1 2024
+0.001%
Number of holders
139
Number of buys Q1 2024
89
Number of sells Q1 2024
-47
Average buys Q1 2024 %
+0.003%
Average sells Q1 2024 %
-0.003%
CUSIP
492327101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 31.1 M $2.06 B +$418 M $66.20 139
2023 Q4 24.8 M $987 M +$92.2 M $39.76 116
2023 Q3 22.8 M $727 M +$8.07 M $31.88 103
2023 Q2 22.4 M $900 M +$13.1 M $40.18 118
2023 Q1 22 M $936 M +$93.6 M $42.70 126
2022 Q4 19.7 M $948 M +$89.1 M $48.02 119
2022 Q3 17.5 M $658 M +$33.2 M $37.62 98
2022 Q2 17.2 M $475 M +$7.91 M $27.63 95
2022 Q1 15.6 M $847 M +$4.51 M $54.38 96
2021 Q4 15.7 M $918 M +$68.3 M $58.51 92
2021 Q3 13.8 M $545 M -$17.1 M $39.56 86
2021 Q2 12.9 M $547 M -$44.3 M $42.47 77
2021 Q1 14.4 M $886 M -$122 M $61.55 81
2020 Q4 15.8 M $1.11 B +$300 M $70.54 78
2020 Q3 11.5 M $442 M +$34 M $38.57 47
2020 Q2 10.9 M $410 M +$409 M $37.51 51